Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide's cardiovascular effects have been studied carefully, and the picture is broadly reassuring — but there are specific heart-related changes worth knowing about before you start. As a prescription-only medicine requiring clinical assessment, tirzepatide affects the body in several ways that touch the cardiovascular system, and a prescriber will weigh all of these against your personal health history. This page walks through what the evidence shows, what to watch for day to day, and the signals that mean you should call someone immediately.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates both the GIP and GLP-1 receptors, a dual mechanism that sets it apart from older weight-loss medicines. GLP-1 receptors are found on heart tissue as well as in the gut, which is why researchers have followed cardiovascular markers closely throughout the clinical programme. The short version: modest weight loss at meaningful scale tends to reduce the load on the heart over time, lowering blood pressure and improving lipid profiles in many patients.
The nuance is that tirzepatide can produce a small, early increase in resting heart rate, typically in the region of a few beats per minute, reported in the SURMOUNT trials and described in the NHS tirzepatide medicines page. For most people this is imperceptible and resolves as the body adjusts. For someone whose resting heart rate is already elevated, or who has an existing arrhythmia, it is a detail worth raising at consultation rather than discovering mid-treatment.
Fluid changes matter too. As tirzepatide reduces appetite and calorie intake, some people eat and drink less than usual in the early weeks, which can affect blood pressure and heart rate together. Staying hydrated is not optional advice, it genuinely affects how your cardiovascular system responds to the medication, particularly in warm weather or if you are exercising more as part of your lifestyle changes.
The official prescribing information (the Summary of Product Characteristics, published on the electronic Medicines Compendium (eMC)) records heart rate increase and palpitations among tirzepatide's side effects. Palpitations (the sensation that your heart is pounding, fluttering or skipping) are uncommon rather than common, meaning they affect fewer than one in a hundred people in the trial data. That is not rare enough to dismiss, but it is not something most patients experience.
Chest discomfort is listed as a potential symptom too. The important distinction is between the brief, position-related discomfort that sometimes accompanies acid reflux (a genuinely common GI side effect of tirzepatide) and chest tightness or pain that feels central, heavy or radiating. One is a digestive nuisance; the other is a reason to stop what you are doing and get help.
A quick checking habit that takes under a minute: press two fingers lightly to the inside of your wrist and count your pulse for 30 seconds, then double it. If your resting heart rate is consistently above 100 bpm after you have been sitting quietly, mention it to your prescriber at your next review. It probably has a straightforward explanation, but it is the kind of finding that belongs in a clinical conversation rather than a search engine.
For a broader picture of tirzepatide's full side-effect profile beyond cardiac effects, our page covering side effects from tirzepatide goes through the complete list in the same measured detail.
Some symptoms should not be monitored, researched or waited out. Get emergency medical help immediately if you experience chest pain or pressure that does not ease within a few minutes; pain spreading to your arm, jaw or back; sudden severe shortness of breath at rest; or a feeling that your heart is beating dangerously fast or irregularly and you feel faint or unwell with it.
These presentations are not on the list because tirzepatide routinely causes them, they are not common side effects. They are on the list because anyone taking any medicine should know that cardiovascular emergencies are time-sensitive, and the presence of a weight-loss injection in your fridge does not change how you should respond to them. Call 999. Tell the crew what medicine you are taking.
Less urgent but still worth prompt attention: persistent palpitations over several days, increasing breathlessness on exertion compared with your usual baseline, or unexplained ankle swelling. These do not need 999, but they do need a call to your GP or prescriber rather than a wait-and-see approach. You can also report suspected side effects to the MHRA directly at the Yellow Card scheme, this matters; it is how post-market safety data is built.
If you want to discuss specific symptoms or pre-existing heart conditions before starting treatment, our Mounjaro heart side effects page covers this in more depth, including what prescribers typically look for in people with cardiac histories.
At a reputable service, the consultation is the safety infrastructure, not an obstacle. At nume, a GPhC-registered Independent Prescriber reads your answers personally before any prescription is issued, your cardiac history, current medicines and blood pressure context all feed into that decision. People with certain conditions (recent acute coronary events, decompensated heart failure, serious untreated arrhythmias) would need specialist input before starting tirzepatide, and a thorough consultation is where that conversation belongs.
Repeat orders are also clinically reviewed, not rubber-stamped. If you have noticed anything cardiovascular between orders, the repeat consultation is the moment to raise it. That ongoing review loop is part of what the Mounjaro treatment overview describes when it explains the structured nature of private prescribing.
Mood changes can accompany any significant weight-loss programme, and the physiological effects of GLP-1 medicines on the brain have their own emerging evidence base; if that is a concern alongside cardiac questions, the tirzepatide mood side effects page covers what is currently known. For questions about day-to-day GI effects that can mimic cardiac symptoms (notably reflux presenting as chest discomfort), the GI side effects page is a useful companion read.
Our prescribers discuss suitability and side effects as part of every consultation. If you have questions about how tirzepatide might interact with your cardiac history, speak to our prescribers, that is exactly what the free consultation is for.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.